Home | Survey | Payment| Talks & Presentations | Job Opportunities
Journals   A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Journal of Clinical Hepatology
1672-5069
2016 Issue 3
How patients with hepatitis B get really recovered
Chen Xinyue;,Liu Yali;
..............page:257-260
Definition and natural history of severe hepatitis B
Guo Wei;,Li Weina;,Ning Qin;
..............page:264-265
Diagnosis and management of patients with hepatic failure:What’s going on?
Chen Yongping;,Xu Lanman;
..............page:266-269
Inhibitory effect of galanin on proinflammatory response induced by lipopolysaccharides in a mouse RAW264.7 macrophage cell line in vitro
he ling zuo ;, li bing hang ;, zhou da ;, liang can can ;, ding yong nian ;, chen yuan wen ;, fan jian gao ;
..............page:270-274
Role of CMKLR1 over-expression in adipose tissues in rat with nonalcoholic steatohepatitis
an xiu qin ;, guo qiao li ;, liu jin chun ;, guo feng tao ;, guo ya rong ;
..............page:279-282
Incidence of metabolic syndrome and non-alcoholic fatty liver diseases in patients with different histological types of lung cancer
zhu zuo yan ;, zuo ji zuo ;, cao hai xia ;, chen guang yu ;, zhu pei ;, zhang rui zuo ;, chen yi ming ;, sun wan zuo ;, yang rui xu ;, yan shi yan ;, fan jian gao ;
..............page:288-291
The correlation between gene polymorphism of acetaldehyde dehydrogenase 2 and drinking features as well as disease onset in patients with alcoholic liver disease
zhang long yu ;, zuo liang ;, hao shu li ;, ye wen hua ;, zhang ji yuan ;, li bao sen ;, huang ang ;, tian hui ;, liu xi qin ;, zou zheng sheng ;
..............page:292-296
Efficacy and safety of glucocorticoid-decreasing-dose therapy in patients with hepatitis B-induced liver failure
long yun ;, liu yun hua ;, deng lan ;, yang li ;
..............page:297-300
Serum M30 and M65 levels in patients with acute-on-chronic pre-liver failure
huang xiao ping ;, wu yun hui ;, wang yan ;, gan jian he ;
..............page:301-304
Efficacy of entecavir monotherapy versus lamivudine combined with adefovir dipivoxil in patients with hepatitis B-associated decompensated cirrhosis:a Meta-analysis
chen bang tao ;, feng xu jiao ;, song shao juan ;, liu ming she ;, zhao zhong fu ;, zhang zuo ;
..............page:305-309
Small intestinal bacterial overgrowth in patients with liver cirrhosis
wei xin peng ;, han ji ao ;, gao xiao ;, yang li ;, ma ying jie ;
..............page:310-313
Effects of cytokine-induced killer cell infusion after transcatheter arterial chemoembolization in treatment of patients with primary liver cancer on preventing portal vein tumor thrombus
song hai yan ;, liu bo ;, zhang jun fei ;, dong jing ;, guo yuan ;, liu li wei ;, chen cong xin ;
..............page:318-321
Diagnosis and treatment of 84 patients with traumatic liver rupture
wang song ping ;, yuan zhong xu ;, liu shu xian ;, liang shan ;, xu zuo sheng ;, wu wen zhou ;, li jian sheng ;
..............page:331-334
Safety and efficacy of ascending doses interferon-α2b combined with ribavirin in treatment of patients with hepatitis-induced liver cirrhosis
zhang guo fan ;, wang fang fang ;, guo chun xia ;, yang zhen hao ;, wang zuo ;, liu wan jun ;
..............page:345-346
Arterial stiffness in patients with nonalcoholic fatty liver disease
wang jing ling ;, ye wen xiong ;, qiu ming yu ;, tong jie ;, zhao yan ;, chen jin jun ;
..............page:347-348,349
Clinical effect of endoscopic variceal ligation in treatment of patients with esophagogastric varices
Wang Peiwen;,Jiang Haiqiong;,Wu Jianjiong;
..............page:349-351
Clinical features of primary biliary cirrhosis:An analysis of 94 cases
Hao Jianhong;,Hao Haiyan;,Hu Y iling;
..............page:352-353
Combination of sorafenib and transcatheter arterial chemoembolization in treatment of patients with primary liver cancer
chen fei ;, he lu lu ;, wang shan ;, bao rui ling ;
..............page:356-357
Risk factors influencing the early postoperative recurrence of the small hepatocellular carcinoma
yu zuo ;, yu hua ;, li xiao huan ;, zhou hong zuo ;, xie zuo ;, xu lu ping ;
..............page:358-359,360
Autoimmune liver diseases:the mist really clears?
Ai Yuemei;,Yan Yujuan;,Xing Yiping;
..............page:360-364
Role of Nrf2 in the regulation of hepatocyte apoptosis
Cui Dan;,Yang Baoshan;
..............page:365-368
Chronic kidney disease in patients with nonalcoholic fatty liver diseases
Lei Ting;,Li Liangping;
..............page:373-376
Advances in the pathogenesis of hepatogenous diabetes
Hu Qingling;,Huang Yaxiong;,Xie Yuanlin;
..............page:377-380
Role of miRNAs in HBV infection and hepatocarcinogenesis
Wang Yi;,Yang Zhenhua;
..............page:381-384
EASL Clinical Practice Guidelines:Liver transplantation
Zhou Xia;,Liu Hongling;
..............page:385-388
The guideline of prevention and treatment for chronic hepatitis B(2015 version)
zhong hua yi xue hui gan bing xue fen hui zhong hua yi xue hui gan ran bing xue fen hui ;
..............page:389-400